B 793 (Rivastigmine tartrate 1.5 mg)
This pill with imprint "B 793" is Yellow, Capsule-shape and has been identified as Rivastigmine tartrate 1.5 mg. It is supplied by Breckenridge Pharmaceutical, Inc..
Rivastigmine is used in the treatment of lewy body dementia; parkinson's disease; alzheimer's disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 1.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
Rivastigmine tartrate
- Imprint:
- B 793
- Strength:
- 1.5 mg
- Color:
- Yellow
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Cholinesterase inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Breckenridge Pharmaceutical, Inc.
- National Drug Code (NDC):
- 51991-0793
More about rivastigmine
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- 18 Reviews – Add your own review/rating
- Drug class: cholinesterase inhibitors
Consumer resources
- Rivastigmine Capsules
- Rivastigmine Oral Solution
- Rivastigmine Patch
- Rivastigmine
- Rivastigmine transdermal
- ... +2 more
Other brands: Exelon
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
